• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Teleradiology Company Launches COVID-19 Screening Program

Article

Siemens Healthineers-backed USARAD begins online CT scan consulting effort.

USARAD, a global teleradiology company backed by Siemens Healthineers, announced this week it will launch a first-of-its-kind screening program to identify patients with COVID-19.

This program, which will operate through USARAD’s SecondOpinions.com division, will connect radiologists to other providers. According to a company statement, chest CT-trained radiologists will provide screening diagnostics and consultations together with other medical specialists, including pulmonologists and infectious disease experts.

Launched in partnership with Medical Diagnostic Web (MDW), a blockchain-powered marketplace that provides access to hundreds of radiologists ready to provide diagnostic assistance, this new program allows providers to upload images through USARAD’s online service 24-hours-a-day. Radiologists will be on-hand to help either diagnose or rule out COVID-19, and as the volume of imaging studies increases, AI algorithms will be available to assist in decision-making.

Alongside its partnership with MDW, USARAD also announced a collaboration with the Israel-based Nanox Imaging to facilitate bringing Nanox’s mobile imaging system to high-risk areas, supporting preventive COVID-19 screening efforts in these locations.

“USARAD, together with its strategic partners, MDW and Nanox, is available to help patients world-wide during the current COVID-19 pandemic by leveraging the latest science and technology,” said Michael Yuz, M.D., USARAD founder and chief executive officer. “We are doing everything possible to reduce panic, bringing the peace of mind to millions of patients world-wide.”

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2025 MJH Life Sciences

All rights reserved.